Pituitary, Thyroid & Adrenal Disorders
Conference Coverage
AML risk is doubled in low-risk thyroid cancer patients unnecessarily given radioactive iodine therapy
MADRID - Unnecessary radioactive iodine treatment is associated with nearly twice the risk of developing acute myeloid leukemia (AML) in patients...
From the Journals
Study reveals limits of 4-D CT scanning for parathyroid disease
Four-dimensional computed tomography can miss some types of parathyroid disease.
Conference Coverage
Big changes coming for thyroid cancer staging
How big an impact will new thyroid staging criteria have on the numbers of stage I disease? It’ll be huge.
Conference Coverage
Contralateral nodal thyroid metastases show slow progression
BOSTON – In some thyroid cancers, a small level III contralateral nodal metastasis may be watched safely rather than resected.
Conference Coverage
Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
Size does matter – at least when it comes to normalizing the serum thyroglobulin level.
Conference Coverage
VIDEO: Less follow-up proposed for low-risk thyroid cancer
BOSTON – Can some patients with good treatment responses safely transition to follow-up monitoring at longer intervals?
Conference Coverage
Is that thyroid nodule malignant?
ESTES PARK, COLO. – Here’s a guideline-backed evaluation strategy for sorting out malignant from benign thyroid nodules.
From the Journals
New trial shows thymectomy benefits myasthenia gravis
New trial moves toward settling thymectomy debate for myasthenia gravis.
From the Journals
Surgeon, primary care collaboration needed to catch hyperparathyroidism
Of 10,432 patients identified with hypercalcemia at the University of Alabama at Birmingham from 2011 to 2015, only 3,200 patients (31%) had a...
From the Journals
Sjögren’s syndrome most common extrahepatic PBC manifestation
Up to 73% of PBC patients also have Sjögren’s syndrome.
From the Journals
USPSTF: No thyroid cancer screening for asymptomatic adults
The harms of screening asymptomatic adults for thyroid cancer outweigh the benefits, according to the U.S. Preventive Services Task Force.